What schedule is butalbital classified under?

Butalbital is classified as a Schedule III controlled substance. This classification indicates that butalbital has a recognized medical use but also has a moderate potential for abuse compared to substances in Schedule I and II. Schedule III drugs can be prescribed by healthcare providers, but they are subject to specific regulations regarding prescribing and dispensing to ensure they are used safely and appropriately.

Butalbital is often included in combination products used to treat headaches and migraines, which reflects its therapeutic usefulness while also necessitating control due to potential misuse or dependency. Understanding these classifications is crucial for pharmacists and healthcare professionals to comply with legal standards and safeguard public health.